{"Ticker": "ALGN", "Company": "Align Technology", "Sector": "Health Care", "Updated": "2022-01-31", "Rating": [{"Date": "2022-01-31", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$880 to $620"}, {"Date": "2022-01-31", "Rating": "Initiated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$575"}, {"Date": "2021-10-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$732"}, {"Date": "2021-08-05", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$732"}, {"Date": "2021-07-09", "Rating": "Upgrade", "Organization": "Stephens", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$600 to $700"}, {"Date": "2021-07-08", "Rating": "Initiated", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform", "Target_Change": "$790"}, {"Date": "2021-04-22", "Rating": "Upgrade", "Organization": "Berenberg", "Rating_Change": "Hold to Buy", "Target_Change": "$683"}, {"Date": "2021-01-04", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$625"}, {"Date": "2020-07-29", "Rating": "Downgrade", "Organization": "Berenberg", "Rating_Change": "Buy to Hold", "Target_Change": "$306"}, {"Date": "2020-07-20", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$280"}, {"Date": "2020-01-09", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": ""}, {"Date": "2019-10-24", "Rating": "Reiterated", "Organization": "BofA/Merrill", "Rating_Change": "Neutral", "Target_Change": "$220 to $240"}, {"Date": "2019-10-07", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2019-07-25", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$340 to $220"}, {"Date": "2019-05-30", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2019-04-18", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Buy", "Target_Change": ""}, {"Date": "2019-02-14", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$275"}, {"Date": "2019-01-17", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$230"}, {"Date": "2018-11-20", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$375 to $343"}, {"Date": "2018-07-26", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$375 to $425"}, {"Date": "2018-07-13", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$350 to $375"}, {"Date": "2018-06-25", "Rating": "Resumed", "Organization": "BofA/Merrill", "Rating_Change": "Buy", "Target_Change": "$420"}]}